Cellular Origins, the Cell and Gene Therapy Catapult, and Resolution Therapeutics have formed a consortium funded by Innovate ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

The Flamma Group, a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late-stage ...

Grand River Aseptic Manufacturing’s Tyler BeVier on strategic partnerships, cutting-edge capacity, and a patient-first ...

Jazz Pharmaceuticals’ Board of Directors has unanimously selected Renee Gala as President and Chief Executive Officer.

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

The Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer is ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...

Ofichem Group has agreed to acquire Avivia B.V., a company specialized in formulation development based in Nijmegen, the ...

Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.

New appointments to the leadership team also include Stefan Larson as Chair of the Board of Directors and Ingmar Bruns as a ...

“With our new hot melt extrusion technology, Aenova is expanding its range of innovative platforms to provide modern, ...